Suchergebnisse - "Shi, Yuankai"

PubPharm (3)

1

Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients : a single-arm, multicenter phase II study (INTELLECT)

enthalten in: BMC medicine | 2023

von Shi, Y. | Chen, J. | Zhang, H. | +30

2

Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer : a multicenter, open-label, first-in-human phase 1 study

enthalten in: BMC medicine | 2022

von Xing, P. | Zhao, Q. | Zhang, L. | +5

3

Toxicity profile of anaplastic lymphoma kinase tyrosine kinase inhibitors for patients with non-small cell lung cancer : A systematic review and meta-analysis

enthalten in: Investigational new drugs | 2022

von Tao, Y. | Zhou, Y. | Tang, L. | +3

1
[1]